1Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-63.
2Cockerill GW, Gamble JR, Vadas MA. Angiogenesis: models and modulators. Int Rev Cytol 1995; 159:113-60.
3Hagedorn M, Andreas B. Target molecules for anti-angiogenic therapy: from basic research to clinical trials. Crit Rev Onco/Hema 2000; 34: 89-110.
4Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1995; 1: 27-31.
5Middlton E J, Kandaswami C, Theoharides CT. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 2000;52: 673-751.
6Fan PS, Gu ZL, Liang ZQ. Effect of quercetin adhesion of platelets to microvascular endothelial cells in vitro. Acta Pharmacol Sin 2001; 22: 857-60.
7Xie ML, Lu Q, Gu ZL. Effect of quercetin on platelet aggregation induced by oxyradicals. Acta Pharmacol Sin 1996; 17:334-6.
8Perez-Vizcaino F, Ibarra M, Cogolludo AL, Duarte J, Zaragoza-Arnaez F, Moreno L, et al. Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J Pharmacol Exp Ther 2002; 302: 66-72.
9Rodgers EH, Grant MH. The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activites of MCF-7 human breast cancer cells. Chem Biol Interact 1998; 116:213-28.
10Takagi T, Takekoshi S, Okabe T, Nagata H. Quercetin, a flavonol, promotes disease of microtubules in prostate cancer cells: possible mechanism of its antitumor activity. Cytochemistry 1998; 31: 435-45.
